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Background: Mosquito saliva plays crucial roles in blood feeding but also evokes in hosts an anti-saliva antibody
response. The IgG response to the Anopheles gambiae salivary protein gSG6 was previously shown to be a reliable
indicator of human exposure to Afrotropical malaria vectors. We analyzed here the humoral response to the salivary
anti-thrombin cE5 in a group of individuals from a malaria hyperendemic area of Burkina Faso.
Methods: ELISA was used to measure the anti-cE5 IgG, IgG1 and IgG4 antibody levels in plasma samples collected
in the village of Barkoumbilen (Burkina Faso) among individuals of the Rimaibé ethnic group. Anti-gSG6 IgG
levels were also determined for comparison. Anopheles vector density in the study area was evaluated by indoor
pyrethrum spray catches.
Results: The cE5 protein was highly immunogenic and triggered in exposed individuals a relatively long-lasting
antibody response, as shown by its unchanged persistence after a few months of absent or very low exposure
(dry season). In addition cE5 did not induce immune tolerance, as previously suggested for the gSG6 antigen.
Finally, IgG subclass analysis suggested that exposed individuals may mount a Th1-type immune response against
the cE5 protein.
Conclusions: The anti-cE5 IgG response is shown here to be a sensitive indicator of human exposure to anopheline
vectors and to represent an additional tool for malaria epidemiological studies. It may be especially useful in
conditions of low vector density, to monitor transiently exposed individuals (i.e. travellers/workers/soldiers spending
a few months in tropical Africa) and to evaluate the impact of insecticide treated nets on vector control. Moreover,
the gSG6 and cE5 salivary proteins were shown to trigger in exposed individuals a strikingly different immune
response with (i) gSG6 evoking a short-lived IgG response, characterized by high IgG4 levels and most likely
induction of immune tolerance, and (ii) cE5 eliciting a longer-living IgG response, dominated by anti-cE5 IgG1
antibodies and not inducing tolerance mechanisms. We believe that these two antigens may represent useful
reagents to further investigate the so far overlooked role of Anopheles saliva and salivary proteins in host early
immune response to Plasmodium parasites.
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The saliva of hematophagous arthropods is a complex
cocktail of bioactive molecules whose main function is
to facilitate blood acquisition by targeting host hemostatic,
inflammatory and immune responses [1,2]. Although vec-
tor saliva originally evolved to assist blood feeding, its in-
jection into the vertebrate skin modulates host immune
responses, which in turn may affect transmission or estab-
lishment of pathogens [3-5]. In addition individuals re-
peatedly bitten by arthropods carry circulating anti-saliva
antibodies that can be exploited as a tool to evaluate hu-
man exposure to disease vectors as diverse as ticks, sand
flies, triatomines, tsetse flies and mosquitoes [6,7]. Ac-
cording to their highly adaptive value, and under the
selective pressure of the host immune system, salivary pro-
teins of blood-feeding arthropods evolve at a very fast rate
as clearly shown in sand flies and mosquitoes [8,9]. Per-
haps also as a consequence of this rapid divergence tran-
scriptome analyses revealed that mosquito saliva includes
not only a relatively large number of family-specific pro-
teins, i.e. found in culicids but in no other blood-feeding
arthropods, but also genus-specific salivary proteins, i.e.
uniquely found in the saliva of either anopheline or culi-
cine mosquitoes [10].
We have previously studied the human antibody re-
sponse to the anopheline-specific gSG6 salivary protein
in a cohort from a malaria hyperendemic area of Burkina
Faso, i.e. in individuals naturally exposed to bites of
Anopheles mosquitoes (mainly Anopheles gambiae and
Anopheles funestus). In An. gambiae gSG6 is specifically
found in the saliva of adult female mosquitoes [11] and
the protein must play some crucial role in blood feeding
since its depletion by RNAi prolongs probing time and
affects blood feeding efficiency [12]. Analysis of the IgG
antibody response to the gSG6 recombinant protein indi-
cated it is a suitable serological marker of human expos-
ure to African malaria vectors in different epidemiological
settings [13-16] and similar results have been obtained
with the less sensitive gSG6-P1 peptide [17-19]. The avail-
ability of simple immunoassays to measure human-vector
contact represents a very useful tool for the evaluation of
malaria transmission intensity and disease risk, especially
in settings where the use of classical entomological
methods is difficult or unfeasible (low malaria transmis-
sion, low/reduced vector density, logistics, etc.). More-
over, since serology with parasite antigens is commonly
used in malaria studies [20] the parallel use of salivary
antigens to obtain information on exposure to vectors
appears very convenient. In this respect the availability
of additional salivary antigens enriching the serological
toolbox would be very valuable, allowing us to over-
come potential problems linked to individual variation
of the immune response and providing reagents with
different immunogenicity, which could be very useful todetect variation in vector exposure in different epi-
demiological settings.
In addition to gSG6 we have also expressed and purified
in recombinant form another An. gambiae salivary protein
that is only found in mosquitoes of the Anophelinae sub-
family, i.e. it is not found in the saliva of culicine mosqui-
toes or other blood-feeding arthropods and shows no
similarity to any other known polypeptide. This protein
was originally named cE5 [21] and then found to be a
member of the anophelin family of anti-thrombin peptides
[22,23]. Initial indications showed that the cE5 protein
was immunogenic in humans, encouraging further investi-
gation of the humoral immune response to this protein in
exposed individuals. We report here an analysis of the
IgG, IgG1 and IgG4 antibody responses to the An. gam-
biae salivary proteins cE5 in a group of individuals from a
malaria hyperendemic area of Burkina Faso. Comparison
of the humoral response to the cE5 and gSG6 salivary pro-
teins clearly indicates that these two proteins evoke sub-
stantially different responses in individuals exposed to
bites of anopheline mosquitoes.
Methods
Study area and subjects
The study was conducted in the village of Barkoumbilen,
located in a rural malaria hyperendemic area of Burkina
Faso (≈35 kilometers NE of Ouagadougou) and inhabited
by the two sympatric ethnic groups Mossi and Rimaibé.
These two groups are both Sudanese Negroid populations
with a remarkably similar response to parasite antigens
and susceptibility to malaria as opposed to individuals of
the sympatric ethnic group Fulani, who are less suscep-
tible to malaria and exhibit higher humoral response to
both parasite and mosquito salivary antigens [15,24-26].
Plasmodium falciparum transmission is intense in the
area, especially during the June–October rainy season (En-
tomological Inoculation Rate (EIR) >100/person/year) and
malaria prevalence is very high, with most of malaria in-
fections (≈95%) caused by P. falciparum. Infection rates in
both the Mossi and Rimaibé groups were of 60%-90% (de-
pending on age) during the high-transmission rainy sea-
son and of 40-80% in the low-transmission dry season.
Samples were collected during three cross-sectional sur-
veys carried out at the beginning (August 1994) and the
end (October 1994) of the high-transmission season, as
well as during the following low-transmission season
(March 1995). Plasmodium falciparum inoculation rates
were based on indoor vector collections and immunoen-
zymatic estimation of circumsporozoite protein positivity
as previously reported [27].
Ethics statement
The study protocol was approved by the Technical
Committee of the Centre National de Lutte contre le
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informed consent for multiple immuno-parasitological,
clinical and entomological surveys was obtained from the
Rimaibé community living in Barkoumbilen. The samples
utilized for this analysis have been collected in the period
from August 1994 to March 1995 in the frame of a larger
epidemiological study performed in Burkina Faso [25]. At
that time a national ethic committee was not yet in place
and written consent was not requested. Therefore, the
study protocol and the oral informed consent were ap-
proved by the Institutional Review Board, i.e. by the Tech-
nical Committee of the Centre National de Lutte contre le
Paludisme of the Ministry of Health of Burkina Faso. Indi-
vidual oral consent was obtained from all adults and from
children’s parents or legal representatives. In June-July
1994, prior to the start of the surveys, meetings were held
in the villages of the study area to explain, in the local lan-
guages, the objectives of the study, the procedures in-
volved and to answer questions from the residents.
Entomological data
Entomological measures were based on indoor pyreth-
rum spray catches carried out monthly between August
and November 1994 and in March 1995 (12 catches/
month). In the study area the main malaria vectors were
An. gambiae, An. arabiensis and An. funestus, with the
members of the An. gambiae species complex (i.e. An.
gambiae and An. arabiensis) representing, on average,
approximately 90% of the indoor-resting anopheline mos-
quitoes. As previously reported, the number of anopheles/
person/night ±95% CI in the village of Barkoumbilen were
6.3 ± 1.5 (August 1994), 12.1 ± 5.4 (September-October
1994) and 0.4 ± 0.2 (March 1995) [15]; additional details
on the study site and parasitological aspects can be found
elsewhere [24,25,27].
Plasma samples
Blood samples were collected in K3-EDTA sterile tubes.
Within 3–4 hr after bleeding, the plasma was transferred
and kept at −20°C until serological tests were done. All
samples analyzed in this study were collected in the vil-
lage of Barkoumbilen among individuals of the Rimaibé
ethnic group. A total of 207 human plasma samples
collected during the Aug 1994 survey (1–74 years old,
average age ±95% CI = 22.7 ± 16.9) were used for (i) the
comparative determination of the anti-cE5 and anti-
gSG6 IgG levels and for (ii) the measurement of anti-
cE5 IgG1 and IgG4 antibodies. The seasonal variation of
the anti-cE5 IgG response was measured in samples col-
lected during three different surveys: Aug 1994 (n = 117,
1–70 years old, 17.2 ± 3.0), Oct 1994 (n = 121, 1–70 years
old, 16.8 ± 3.1) and Mar 1995 (n = 121, 1–70 years old,
16.0 ± 2.9). Fifty-nine plasma samples from randomly
selected individuals (1–69 years old, 26.3 ± 16.1) whoreferred to a public hospital of Rome’s municipality for
routine blood tests were used as unexposed controls.
Enzyme-linked immunosorbent assays
ELISA was performed according to standard procedures.
The gSG6 and cE5 proteins were expressed and purified
as previously described [15,22]. Flat-bottom, 96-well plates
(Nunc Maxisorp, M9410) were coated overnight with
50 μl of either gSG6 or cE5 at 5 μg/ml diluted in coating
buffer (15 mM Na2CO3, 35 mM NaHCO3, 3 mM NaN3,
pH 9.6). Wells were washed four times with PBST (0.05%
Tween-20 in 1x PBS), blocked for 3 hours at 25°C (150 μl
1% w/v skimmed dry milk in PBST), washed again as
above and incubated overnight at 4°C with 50 μl of plasma
diluted 1:100 (IgG) or 1:20 (IgG1 and IgG4). Plates were
then washed as above and incubated for 3 hours at 25°C
with 100 μl of polyclonal rabbit anti-human IgG/HRP
(Dako P0214, dilution 1:5000 in blocking buffer) or 100 μl
of sheep anti-human IgG1/HRP (Binding Site AP006,
dil. 1:1000) or 100 μl of sheep anti-human IgG4/HRP
(Binding Site AP009, dil. 1:1000). After washing the
colorimetric reaction was carried out with 100 μl of o-
phenylenediamine dihydrochloride (OPD, Sigma P8287;
15 min, 25°C in the dark). Reactions were terminated by
adding 25 μl of 2 M H2SO4. OD492 were determined
using a microplate reader (Biotek Synergy HT). IgG1
and IgG4 OD levels were converted to concentrations
(ng/ml) using standard curves set up as follows. As cap-
turing factors goat anti-human IgG (5 μg/ml; Jackson
ImmunoResearch Laboratories Inc, PA, USA) or mouse
anti-human IgG4 (2 μg/ml; BD Pharmingen, USA) were
used for coating (50 μl coating buffer, overnight at 4°C).
After washing, blocking and washing again as above wells
were incubated overnight at 4°C with serial dilutions, from
1 μg/ml to 0.0078 μg/ml (1→ 0.5→ 0.25→ 0.125→
0.0625→ 0.03125→ 0.0156→ 0.0078), of purified native
human IgG1 or IgG4 (ABD Serotec, Kidlington, Oxford,
UK) in 50 μl of blocking reagent. Incubation with anti-
human IgG1/HRP or IgG4/HRP and colorimetric detec-
tion were performed as described above.
Data analysis
IgG, IgG1 and IgG4 levels were determined by analyzing
samples in duplicate with the antigen and once without
antigen (coating buffer only). Final OD was calculated as
the mean OD value with antigen minus the OD value
without antigen. Serial dilutions of a pool of plasma sam-
ples were added to each plate as standard curve to
normalize experimental variability among plates. The two-
fold serial dilutions were 1:30 to 1:960 for IgG determin-
ation and 1:4 to 1:512 for IgG1 and IgG4. Intra and inter
assay variation of standard samples was always below 20%.
The very few samples whose duplicates showed a coeffi-
cient of variation >20% were not included in the analysis.
Figure 1 IgG antibody response to the An. gambiae cE5 and
gSG6 proteins. Comparison of the anti-cE5 and anti-gSG6
IgG responses among exposed individuals during the malaria
transmission season (survey Aug 1994, n = 207, average age ±95%
CI = 22.7 ± 16.9). (A) Box plots of OD values among responders to
both cE5 and gSG6 antigens (n = 156). Boxes display median values,
25th and 75th percentiles. Whiskers represent 5–95 percentiles
and dots the outliers. The IgG response to the cE5 protein in
non-exposed individuals (n = 59, average age ±95% CI = 26.3 ± 16.1)
is shown as control (C). IgG levels are expressed as OD492. P value
determined by the Wilcoxon matched-pairs signed rank test
(****, p < 0.0001). (B) Seroprevalence of anti-cE5 and anti-gSG6
IgG antibodies. Error bars indicate 95% confidence intervals.
P value determined by Fisher’s exact test (****, p < 0.0001).
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Wallis test. The Mann–Whitney U test was used to
compare two independent groups and the Wilcoxon
matched-pairs test was used for comparison of two paired
groups. Proportions were compared by the Fisher’s exact
test. Receiver Operating Characteristic (ROC) curve ana-
lysis were used to obtain information on the accuracy of
the assays and to calculate cut-off values for seropositivity
as follows: Aug 1994 IgG cE5 > 0.0705 (95.19% sensitivity,
96.61% specificity, area under curve 0.9808), Aug 1994
IgG gSG6 > 0.0645 (77.88% sensitivity, 84.75% specificity,
area under curve 0.8610), Aug 1994-Oct 1994-Mar 1995
IgG cE5 > 0.06786 (92.48% sensitivity, 94.12% specificity,
area under curve 0.9684). All statistical analyses were per-
formed using GraphPad Prism 6.0 statistical software
(GraphPad Software Inc., La Jolla, CA).
Results
cE5 immunogenicity
Following initial indications of cE5 immunogenicity to
humans we measured IgG antibody levels in samples
collected during the malaria transmission season (Aug
1994, n = 207) in the village of Barkoumbilen, Burkina
Faso. As a comparison we also analyzed the response of
the same individuals to the An. gambiae salivary protein
gSG6, whose antigenic properties have been previously
investigated [14-16,26]. IgG antibodies against the cE5
protein were elevated in exposed individuals but very
low, or absent, in unexposed control subjects (Figure 1A).
In addition, anti-cE5 IgG levels were significantly higher
than anti-gSG6 IgG levels, as indicated by a comparison
of the OD values among responders. Similarly, the sero-
prevalence was significantly higher for the cE5 (94%)
than for the gSG6 antigen (78%, Figure 1B). According to
these observations the An. gambiae salivary protein cE5
appeared to be immunogenic in humans and to evoke in
exposed individuals an IgG response of higher intensity in
comparison to gSG6.
IgG response to the cE5 and gSG6 proteins in different
age groups
The IgG antibody response to the salivary protein gSG6
was previously found to be higher in young children
than in adults or elderly people. As a possible explan-
ation of this age-dependent pattern it was suggested that
the continued and intense exposure to bites of anophel-
ine mosquitoes induced immune tolerance to this anti-
gen [15,26]. Fully consistent results where obtained in
the present study where median anti-gSG6 IgG levels and
seroprevalence were higher in 1–15 years old individuals
than in the other two age groups (Figure 2A-B). On the
contrary, a different trend was observed for the cE5
salivary protein: anti-cE5 IgG levels were significantly
higher in individuals older than 30 years although nodifference was observed when seroprevalence was consid-
ered, most likely because of the very high values found in
all age groups (>90%, Figure 2A-B). A consistent pattern
was also observed when the youngest age group was fur-
ther stratified in very young (1–5 years old), young (6–10
years old) and older (11–15 years old) children (Additional
file 1: Figure S1). The difference in the IgG response to
the two antigens studied appeared especially striking when
individual OD values were reported as a function of age
(Figure 2C): the two divergent best fit lines (significantly
non-zero: gSG6, p = 0.0111; cE5, p = 0.0003) clearly show
opposite trends for the IgG response to gSG6 and cE5.
Figure 2 Comparison of the IgG response to cE5 and gSG6 in
different age groups. (A) Box plots of OD values among responders
to cE5 (1–15 n = 94; 16–30 n = 50; >30 n = 53) and to gSG6 (1–15
n = 84; 16–30 n = 40; >30 n = 38) in the three age groups as indicated.
Boxes, whiskers and dots as in Figure 1. IgG levels are expressed as
OD492. P values determined by the Kruskal-Wallis (cE5 P = 0.001; gSG6
ns) and the Mann–Whitney tests (***, p < 0.001; **, p < 0.01). (B)
Seroprevalence of anti-cE5 and anti-gSG6 IgG antibodies in the different
age groups (1–15 n = 97; 16–30 n = 52; >30 n = 58). Error bars and
P value as in Figure 1 (***, p < 0.001). (C) Scatter plot reporting
the IgG antibody response to cE5 (red) and to gSG6 (black) as
function of age (n = 207). The best-fit lines (solid) and 95% CI
(broken lines) are shown. Note that one data point is outside
the axis limits.
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gests that the An. gambiae cE5 does not induce immune
tolerance, even after prolonged and intense exposure.
Anti-cE5 IgG1 and IgG4 subclasses in exposed individuals
Human IgG response to mosquito bites is known for be-
ing mainly characterized by saliva-specific antibodies of
the IgG1 and IgG4 subclasses [28-30]. For this reason,
and to obtain further insights into the human antibody
response to the cE5 salivary protein, we also determined
anti-cE5 IgG1 and IgG4 levels in the plasma of the same
individuals previously analyzed (Aug 1994, n = 207).
Median anti-cE5 IgG1 levels were significantly higher
than IgG4 levels in exposed individuals (Figure 3A).
This was independent of the specific age group considered
(1–15, 16–30 or >30 years old, not shown; Wilcoxon test
p < 0.0001) as clearly summarized by the scatter plot in
Figure 3B. Therefore IgG1 appeared to be the dominant
anti-cE5 IgG subclass, a finding substantially different
from that previously reported for the response to the
gSG6 protein, which is characterized by high IgG4 levels
and by a switch from IgG1 to IgG4 taking place in chil-
dren before ten years of age [26].
Temporal variation of the anti-cE5 IgG response
In order to better understand the kinetics of mounting
and declining of the IgG response against the cE5 pro-
tein we measured anti-cE5 IgG antibodies in three sets
of samples collected in the village of Barkoumbilen at
the beginning (Aug 1994, n = 117) and at the end (Oct
1994, n = 121) of the high transmission/rainy season, as
well as during the following low transmission/dry period
(Mar 1995, n = 121). As also previously reported [15], in
Aug and Oct 1994 vector density in the study area was
high (number of anopheles/person/night was 6.3 ± 1.5
and 12.1 ± 5.4, respectively) while the number of anoph-
eline mosquitoes showed a marked decrease during the
dry season (0.4 ± 0.2 in Mar 1995). Comparison among
cE5 responders indicated that IgG antibody levels did
not change during the transmission season (Aug vs Oct),
Figure 3 Anti-cE5 IgG1 and IgG4 responses. (A) Box plots of
anti-cE5 IgG1 and IgG4 levels among the 207 individuals of the Aug
1994 survey. Boxes, whiskers, dots and P value as in Figure 1. IgG1
and IgG4 levels are expressed in ng/ml. (B) Scatter plot reporting
the IgG1 (red) and IgG4 (black) antibody response to cE5 as function
of age (n = 207). The best-fit lines (solid) and 95% CI (broken lines)
are shown. Note that three data points are outside the axis limits.
Figure 4 Seasonal pattern of the anti-cE5 IgG response. IgG
response to the cE5 protein in the three surveys: Aug 1994 (n = 117,
average age ±95% CI = 17.2 ± 3.0), Oct 1994 (n = 121, average
age ±95% CI = 16.8 ± 3.1) and Mar 1995 (n = 121, average age ±95%
CI = 16.0 ± 2.9). (A) Box plots of OD values among responders from
the different surveys as indicated. Boxes, whiskers and dots as in
Figure 1. IgG levels are expressed as OD492. (B) Seroprevalence of
anti-cE5 IgG antibodies. Error bars as in Figure 1.
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addition, and more importantly, no decrease was observed
during the dry season (Aug/Oct vs Mar) when a drop in
vector density was recorded (Figure 4A). Identical results
were obtained when the population was stratified in differ-
ent age groups (not shown) and also seroprevalence was
always very high (>90%) with no difference between the
rainy and the dry seasons (Figure 4B). Similarly, no
seasonal variation was observed when the comparison was
restricted to the seventy-seven individuals for which
plasma samples from the three different surveys were
available. However, when the population was analyzed by
age group, a significant decrease of the IgG level was
found only in the group of youngest children, i.e. 1–5
years old (Additional file 2: Figure S2). Overall, these
observations suggest that the anti-cE5 IgG antibody re-
sponse is not short-lived and does not decay after a fewmonths of very low or absent exposure as reported pre-
viously for both whole anopheles saliva [31] and the
gSG6 antigen [15].
Discussion
Mosquito salivary repertoires are known to include around
one hundred secretory proteins and comparative analyses
indicated that Anopheles mosquitoes carry in their saliva at
least ten genus-specific proteins, i.e. not found in the saliva
of Aedes or Culex species or in other blood feeding arthro-
pods [1,10]. These proteins, if immunogenic to humans,
may be ideal candidates for the development of innova-
tive serological markers to evaluate human exposure to
malaria vectors. We previously reported that one of
these anopheline-specific salivary polypeptides, the An.
gambiae gSG6, appeared to be a reliable marker of human
exposure to Afrotropical malaria vectors as shown by
studies in Burkina Faso, Tanzania and Uganda [13-16].
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suitable to evaluate efficacy of insecticide-treated nets
(ITN) for malaria vector control [32].
More recently we set up conditions for expression in re-
combinant form of the An. gambiae salivary anti-thrombin
cE5 [22] and became aware of its immunogenicity. Consid-
ering the intrinsic variability of the individual immune
response and the wide range of exposure to anopheline
vectors in malaria endemic areas, it follows that the avail-
ability of additional markers would be very desirable.
Therefore, we decided to compare the antibody response
to cE5 and gSG6 in naturally exposed individuals from a
malaria hyperendemic area of Burkina Faso. Among the
207 Rimaibé analyzed for their humoral response to both
antigens we found ≈ 94% and ≈ 78% seropositivity with cE5
and gSG6, respectively (39 individuals responded only to
cE5 and 6 only to gSG6). This finding clearly points to the
high immunogenicity of cE5 which, along with the elevated
vector density in the study area, explains the very high level
of seropositivity.
To get some insights into the kinetics of the anti-cE5
antibody response we also measured specific IgG levels
in samples collected at different time points: during the
rainy season, i.e. in August and October when vector
density is very high, and during the dry period (March)
when there is a drop in vector density. No changes of
the anti-cE5 IgG level or seroprevalence were observed.
In the same epidemiological setting (identical village and
surveys) we previously reported seasonal variation of the
anti-gSG6 IgG response in individuals from the sympatric
Mossi ethnic group: the IgG response to gSG6 increased
from August to October with the continued exposure to
anophelines and decreased in March, after a few months
of very low or absent exposure [15]. The observations re-
ported here clearly indicate that the cE5 An. gambiae sal-
ivary protein evokes in exposed individuals a relatively
long-lasting antibody response, as opposed to the short-
lived IgG response previously found for the gSG6 antigen.
It should be pointed out that the sympatric ethnic groups
Mossi and Rimaibé, who have been the subject of quite a
few investigations related to genetic susceptibility to mal-
aria, always showed very similar humoral response to all
antigens tested so far [24,25]. For these reasons it seems
unlikely that the difference in the response to these two
antigens is connected to ethnicity, although this possibility
cannot be completely ruled out.
It will be interesting to understand for how long the
anti-cE5 IgG response persists in the absence of expos-
ure to anophelines. This question could be addressed
following subjects transiently exposed to bites of anophel-
ine mosquitoes, for example travellers or workers spend-
ing a few months in tropical Africa. However, it should be
taken into account that short-time exposures may not
allow reaching a steady state, as suggested by the decreaseof the anti-cE5 IgG response observed during the dry sea-
son in the eleven children under 5 years of age for which
plasma samples were available from the three different
surveys (Additional file 2: Figure S2). A possible alterna-
tive, in the absence of a suitable human challenge model,
may be the use of a laboratory animal model (i.e. mice). In
any event, the high sensitivity of the cE5 antigen suggests
that it may be useful especially in situations of low vector
density and perhaps to evaluate the impact of vector con-
trol measures such as the application of ITN or of long-
lasting insecticide treated nets (LLIN).
The IgG antibody response to the cE5 and gSG6 saliv-
ary antigens also showed a striking difference in the way
it evolves in individuals continuously exposed to anoph-
eles bites throughout their life. The anti-cE5 IgG re-
sponse increased with age, being less intense in children
and reaching a maximum in adults after the age of thirty;
this pattern is very similar to the one typically observed
with different P. falciparum antigens in the same epi-
demiological setting [24,25]. On the contrary, as previ-
ously reported, anti-gSG6 IgG antibody levels tend to
decrease according to age, most likely due to the induction
of immune tolerance as also suggested by the high level of
anti-gSG6 IgG4 antibodies and by the switch from IgG1 to
IgG4 taking place in children [26]. A different pattern was
found for the anti-cE5 IgG1 and IgG4 responses: IgG1
levels were always higher than IgG4 in all age groups, sug-
gesting that the cE5 antigen does not induce immune tol-
erance and evokes an IgG1-dominated response, likely of
the Th1-type.
In summary the results reported here clearly show that
the two An. gambiae genus-specific salivary proteins
gSG6 and cE5 trigger, in individuals naturally exposed to
bites of anopheline mosquitoes, IgG antibody responses
which are considerably different. The gSG6 protein evokes
an IgG response of short-living nature, that is characterized
by high anti-gSG6 IgG4 antibody levels and apparently in-
ducing immune tolerance; on the contrary, the cE5 protein
elicits a longer-living IgG antibody response, which does
not seem to induce tolerance mechanisms and is character-
ized by higher concentration of anti-cE5 IgG1 antibodies.
Predominant antigen-specific IgG1 and IgG4 antibody re-
sponses can be considered as indicators of Th1- and Th2-
type polarization, respectively [33]. This consideration has
some interesting implications since most arthropod-borne
pathogens are introduced into vertebrate hosts in the con-
text of vector saliva, whose immuno-modulatory properties
may play relevant roles in pathogen transmission or estab-
lishment [5]. A common theme seems to be the ability of
arthropod saliva to skew the host immune response by
down-regulating Th1 cytokines (i.e. IFN-γ, IL-2) and up-
regulating Th2 cytokines (i.e. IL-4, IL-6, IL-10) and creat-
ing an anti-inflammatory immunosuppressive environment
that favors pathogen establishment as previously reported
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history and timing of exposure to saliva may be critical
as shown in a murine model of leishmaniasis. Indeed,
sand fly saliva exacerbated Leishmania infection in
naïve mice but had a protective effect in mice immu-
nized by pre-exposure to bites of uninfected sand flies
[34,40]. According to the most likely interpretation of
these results, saliva immunization elicited a delayed-
type hypersensitivity (DTH) Th1-type response at the
bite site with early recruitment of immune cells and estab-
lishment of a pro-inflammatory environment unfavorable
for Leishmania [34,40,41]. Moreover, also vaccination with
individual sand fly salivary proteins inducing a DTH Th1-
type response (with up-regulation of IFN-γ) was able to
confer protection against Leishmania infection both in a
mice and in a hamster model, indicating the possibility to
exploit arthropod salivary proteins as a sort of adjuvants
for vaccine development [42,43].
Only few studies on the effects of Anopheles mosquito
saliva on Plasmodium transmission are reported in the
literature, likely also due to the traditional assumption of
malariologists that injected sporozoites rapidly abandon
the inoculation site entering the blood stream to reach
the liver. However, this view has recently changed: intra-
vital fluorescence microscopy studies in murine models
revealed that up to 50% of injected sporozoites stay in the
skin, partly reaching draining lymph nodes and partly, be-
fore dying, going through further development up to mer-
ozoites in the dermis, epidermis or hair follicles [44-46].
These observations and recent studies on the early steps
of Plasmodium infection of the mammalian host in mur-
ine models clearly pointed out that CD8+ T lymphocytes
protective against malaria liver stages are primed in lymph
nodes draining the inoculation site [47], highlighting the
crucial role of the skin stage in malaria infection and im-
munity [48-50]. The possible effect of Anopheles saliva on
immune response to Plasmodium parasites is still subject
of debate. Some studies in murine malaria models showed
that mice immunization by pre-exposure to bites of unin-
fected An. stephensi had a protective effect on the follow-
ing infection with P. yoelii [51] or P. chabaudi [52]. In
another investigation, however, An. stephensi saliva did
not enhance infectivity of P. yoelii or P. berghei sporozoites
and had no protective effect upon mice pre-immunization
[53]. These contradictory observations may be, at least
partly, explained by differences in the experimental sys-
tems. However, their interpretation is further complicated
by the fact that blood feeding arthropod saliva is a com-
plex cocktail whose components may have different and
even contrasting effects (enhancing or suppressive) on
host innate and adaptive immunity. Moreover, the specific
effect may also be dose-dependent as the introduction into
the skin of sub microgram amounts of antigens may
induce immunosuppressive, antigen-specific T regulatorycells [48]. We believe that the use of individual salivary
components as the An. gambiae cE5 and gSG6 proteins,
rather than whole mosquito saliva, may be of great help in
simplifying and standardizing the experimental systems
and may contribute to shed some light on these intricate
relationship between vector, parasite and vertebrate host.
Conclusions
To our knowledge the An. gambiae gSG6 and cE5 are
the first salivary proteins from an anopheline mosquito
shown to trigger in naturally exposed individuals a quali-
tatively different immune response, most likely of the
Th2- and Th1-type, respectively. We believe that the re-
combinant gSG6 and cE5 proteins described here may
represent very useful reagents not only for malaria epi-
demiological studies to evaluate human exposure to mal-
aria vectors but also to further investigate the involvement
of Anopheles saliva/salivary proteins in the transmission
and immunity to Plasmodium parasites.
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